simendan has been researched along with Cardiovascular Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Adamowitsch, N; Berger, C; Clement, T; Fleischmann, E; Fraunschiel, M; Graf, A; Horvath, K; Kabon, B; Kuhrn, M; Reiterer, C; Taschner, A; Treskatsch, S | 1 |
| Chen, CY; Chen, TL; Lee, CT; Lin, YC; Yeh, YC | 1 |
| Babik, B; Bertalan, A; Bogáts, G; Csomós, Á; Gombocz, K; Hartyánszky, I; Hejjel, L; Koszta, G; Molnár, A; Németh, E; Nyolczas, N; Paulovich, E; Prodán, Z; Sápi, E; Sax, B; Székely, L; Szerafin, T; Szolnoky, J; Szudi, L; Zima, E | 1 |
| Azzolini, ML; Dossi, R; Landoni, G; Silvani, P; Silvetti, S; Zangrillo, A | 1 |
| Algotsson, L; Alvarez, J; Argyriadou, H; Ben-Gal, T; Černý, V; Cholley, B; Eremenko, A; Guarracino, F; Guerrero-Orriach, JL; Heringlake, M; Järvelä, K; Karanovic, N; Kivikko, M; Lahtinen, P; Lomivorotov, V; Mehta, RH; Mušič, Š; Öwall, A; Pollesello, P; Rex, S; Riha, H; Rudiger, A; Salmenperä, M; Szudi, L; Toller, W; Tritapepe, L; Wyncoll, D | 1 |
| Fox, CJ; Kaye, AD; Liu, H; Zhang, S | 1 |
| Maharaj, R; Metaxa, V | 1 |
| Algotsson, L; Caimmi, P; De Hert, SG; Édes, I; Filippatos, G; Follath, F; Fruhwald, S; González, MJ; Grossini, E; Guarracino, F; Jörgensen, K; Kivikko, M; Landoni, G; Leppikangas, H; Mebazaa, A; Meyer, S; Morelli, A; Papp, Z; Parissis, JT; Parkhomenko, A; Pollesello, P; Salmenperä, M; Schwinger, RH; Wikström, BG; Yilmaz, MB | 1 |
| Biala, A; Finckenberg, P; Korpi, A; Levijoki, J; Loytainen, M; Martonen, E; Mervaala, E | 1 |
| Ambrosi, P; Andréjak, M; Gayet, JL | 1 |
| Barisin, A; Barisin, S; Bradic, N; Husedzinovic, I; Sonicki, Z; Tonkovic, D | 1 |
7 review(s) available for simendan and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of levosimendan for perioperative cardiovascular dysfunction in patients receiving cardiac surgery: a meta-analysis with trial sequential analysis.
Topics: Cardiac Surgical Procedures; Cardiotonic Agents; Cardiovascular Diseases; Humans; Perioperative Period; Randomized Controlled Trials as Topic; Simendan | 2017 |
A systematic review on levosimendan in paediatric patients.
Topics: Adolescent; Cardiotonic Agents; Cardiovascular Diseases; Child; Child, Preschool; Humans; Hydrazones; Infant; Infant, Newborn; Pediatrics; Pyridazines; Randomized Controlled Trials as Topic; Simendan | 2015 |
Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion.
Topics: Cardiac Surgical Procedures; Cardiotonic Agents; Cardiovascular Diseases; Clinical Trials as Topic; Europe; Humans; Hydrazones; Perioperative Care; Preoperative Care; Pyridazines; Simendan | 2015 |
Cardiovascular pharmacology: an update.
Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Diastole; Heart Failure; Humans; Hydrazones; Muscle Contraction; Myofibrils; Natriuretic Peptide, Brain; Nicardipine; Pyridazines; Pyridines; Sarcomeres; Simendan; Urea | 2010 |
Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials.
Topics: Cardiovascular Diseases; Humans; Hydrazones; Myocardial Revascularization; Pyridazines; Randomized Controlled Trials as Topic; Simendan | 2011 |
Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan.
Topics: Animals; Cardiotonic Agents; Cardiovascular Diseases; Clinical Trials as Topic; Consensus; Humans; Hydrazones; Pyridazines; Simendan; Vasodilator Agents | 2012 |
[The best of clinical pharmacology in 2002].
Topics: Anticholesteremic Agents; Antihypertensive Agents; Azetidines; Cardiovascular Diseases; Ezetimibe; Hormone Replacement Therapy; Humans; Hydrazones; Hypercholesterolemia; Losartan; Myocardial Infarction; Natriuretic Agents; Natriuretic Peptide, Brain; Neovascularization, Physiologic; Nicorandil; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Vasodilator Agents | 2003 |
2 trial(s) available for simendan and Cardiovascular Diseases
| Article | Year |
|---|---|
Effect of perioperative levosimendan administration on postoperative N-terminal pro-B-type natriuretic peptide concentration in patients with increased cardiovascular risk factors undergoing non-cardiac surgery: protocol for the double-blind, randomised,
Topics: Biomarkers; Cardiovascular Diseases; Heart Disease Risk Factors; Humans; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Simendan | 2022 |
Levosimendan in off-pump coronary artery bypass: a four-times masked controlled study.
Topics: Anesthesia; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Cardiovascular Diseases; Coronary Artery Bypass; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Monitoring, Intraoperative; Pyridazines; Simendan; Ventricular Function, Left | 2004 |
2 other study(ies) available for simendan and Cardiovascular Diseases
| Article | Year |
|---|---|
[Perioperative use of levosimendan in cardiac surgery. Hungarian recommendation].
Topics: Cardiac Surgical Procedures; Cardiotonic Agents; Cardiovascular Diseases; Humans; Hungary; Hydrazones; Preoperative Care; Pyridazines; Simendan | 2018 |
Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Diet, Sodium-Restricted; Echocardiography; Heart; Heart Failure; Heart Rate; Hydrazones; Hypertension; Kidney; Male; Myocytes, Cardiac; Pyridazines; Rats; Rats, Inbred Dahl; RNA, Messenger; Simendan; Sodium Chloride, Dietary; Sodium, Dietary; Tetrazoles; Valine; Valsartan; Vasodilator Agents; Ventricular Remodeling | 2011 |